Pharmacology

Additional Benefit Of Eribulin For Metastatic Or Locally Advanced Breast Cancer Confirmed

The German Federal Joint Committee (G-BA), the supreme decision-making body of the self-governing medical system in Germany, announced that it considers the use of Halaven(R) (eribulin) to have additional benefit versus comparative treatments, defined by ...

Article - Anna Ohlden - Apr 20 2012 - 11:00am

Positive CHMP Opinion In Europe Of Ferumoxytol For Iron Deficiency Anemia In Adult Chronic Kidney Disease

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for ferumoxytol, a new intravenous (IV) iron therapy with a proposed indication for the treatment of iron deficiency anaemia (ID ...

Article - Anna Ohlden - Apr 20 2012 - 12:00pm

ONO-4641 Reduced Number Of Multiple Sclerosis Lesions In Phase II Trial

ONO-4641,  an investigational oral drug, reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented this week at the American Academy of Neurology Meeting in New Orleans. ...

Article - News Staff - Apr 23 2012 - 4:03am

Positive Top-Line Results From Phase 3 Study Of Ferric Citrate (Zerenex) In Japan

...

Article - Anna Ohlden - Apr 23 2012 - 10:00am

Modafinil has the potential for addiction

A group of neuroscientists and ethicists have recently published a paper warning about the perils of the use of pharmacological drugs for cognitive enhancement by healthy individuals. The paper can be found here: http://www.tandfonline.com/doi/abs/10.1080/ ...

Blog Post - Adm Mohamed - Apr 24 2012 - 4:03pm

Positive Phase 2 Study Met Primary End Point For Investigative Use Of Vyvanse In Adults With Binge Eating Disorder

Shire plc today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder. Following discussions with the US Food and Drug A ...

Article - Anna Ohlden - Apr 27 2012 - 4:00am

Gabapentin Helps Marijuana Addicts Kick The Habit

Researchers have presented clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, also helps people to quit smoking marijuana (cannabis). Unlike traditional addiction treatments, gabapentin targets stres ...

Article - News Staff - Apr 29 2012 - 12:30am

StarCap 1500® Co-Processed Starch Excipient Receives Pharmaceutical Precedence Of Use In The European Union

StarCap 1500® a co-processed excipient has recently gained precedence of use within the European Union (EU) in an approved drug product.  StarCap 1500 is comprised of both corn starch and pregelatinized starch and is designed specifically for use in pharm ...

Article - Anna Ohlden - Apr 30 2012 - 11:27am

Cranberry Capsule Shown To Cure Bladder Infection

Cranberries are known to help with  bladder and urinary tract infections and cranberry capsules do also, without known side effects, according to Dutch company Medical Brands, which has obtained a Class IIa Medical Device Status for its patented Cranberry ...

Article - Anna Ohlden - May 5 2012 - 3:30am

Pixuvri Approved For Adult Patients With Refractory Aggressive Non-Hodgkin B-Cell Lymphomas

Cell Therapeutics, Inc. ("CTI") today announced that it has received conditional marketing authorization from the European Commission ("EC") for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply rela ...

Article - Anna Ohlden - May 11 2012 - 2:30am